Completely Activated and Phase-Transformed Kfemnhcf for Zn/K Hybrid Batteries with 14500 Cycles by an OH-rich Hydrogel Electrolyte.
Chuan LiQing LiZhuoxi WuYiqiao WangRong ZhangHuilin CuiYue HouJiahua LiuZhaodong HuangChunyi ZhiPublished in: Advanced materials (Deerfield Beach, Fla.) (2023)
Metal hexacyanoferrates have been recognized as superior cathode materials for zinc and zinc hybrid batteries, particularly the Prussian blue analogue (PBA). However, PBA development has been hindered by several limitations, including small capacities (< 70 mAh g -1 ) and short lifespans (<1000 cycles). These limitations generally arise due to incomplete activation of redox sites and structure collapse during intercalation/deintercalation of metal ions in PBAs. According to this study, the adoption of a hydroxyl-rich (OH-rich) hydrogel electrolyte with extended electrochemical stability windows (ESWs) can effectively activate the redox site of low-spin Fe of the K x Fe y Mn 1-y [Fe(CN) 6 ] w ·zH 2 O (KFeMnHCF) cathode while tuning its structure. Additionally, the strong adhesion of the hydrogel electrolyte inhibits KFeMnHCF particles from falling off the cathode and dissolving. The easy desolvation of metal ions in the developed OH-rich hydrogel electrolytes can lead to a fast and reversible intercalation/deintercalation of metal ions in the PBA cathode. As a result, the Zn||KFeMnHCF hybrid batteries achieve the unprecedented characteristics of 14500 cycles, a 1.7 V discharge plateau, and a 100 mAh g -1 discharge capacity. The results of this study provide a new understanding of the development of zinc hybrid batteries with PBA cathode materials and present a promising new electrolyte material for this application. This article is protected by copyright. All rights reserved.
Keyphrases
- ion batteries
- solid state
- ionic liquid
- drug delivery
- hyaluronic acid
- aqueous solution
- solar cells
- reduced graphene oxide
- quantum dots
- wound healing
- gold nanoparticles
- oxide nanoparticles
- room temperature
- pseudomonas aeruginosa
- electronic health record
- staphylococcus aureus
- water soluble
- mass spectrometry
- escherichia coli
- candida albicans
- molecularly imprinted